David Schlissel

By asking and answering the right questions, PE firms can better ensure they have a leader in place who can drive value and push the company toward a successful exit. Here are four key themes to consider: https://lnkd.in/ge-qCF9A

1

Deal activity remains lethargic as of September 2024 as it continues to be impacted by high capital costs and regulatory scrutiny. However, sectors like pharma services are showing growth, and projections suggest a rebound in 2025. Looking for more on the latest trends and transaction activity across the industry?

11

FTI Consulting's Corporate Finance & Restructuring segment has earned multiple industry awards, showcasing our outstanding client service! These recognitions highlight our teams' dedication and expertise in driving client success. Check out the full press release: https://lnkd.in/eZ3CvmfV #ExpertsWithImpact #TMA #GlobalMANetwork #TheConsultingReport

4

For private equity firms, an effective value creation plan should include an acquisition performance management framework and tools to bridge value creation measures with business performance. Asking these four questions can help turn your investment thesis into equity gains. #privateequity #valuation https://okt.to/aHneKM

4

Read this HFMA article where Chad Mulvany from the Forvis Mazars US Healthcare Practice shares his insights on rising underinsurance rates across the country: https://lnkd.in/gDsqYAdQ

3

Join us on July 26, 2024, for the Semiannual IPO and M&A Outlook webcast! Discover the latest trends and insights in the IPO and M&A market, and gain valuable knowledge about venture investment in today's dynamic market environment. Don't miss out on this opportunity! #webcast #IPO #MA #ventureinvestment #PrivateEnterprise https://bit.ly/3WlX7Nj

2

Despite high borrowing costs and extended hold times in 2024, dealmaking in healthcare #PrivateEquity surged, marking the second-highest year on record. Our annual report explores four trends that defined deals globally and reshaped the healthcare PE landscape. Read our insights on the year in review and the outlook for what lies ahead. https://bit.ly/40qHI09

1

In the dynamic, high-stakes environment of private equity investment where competitive edge is critical, the role of cybersecurity is often overlooked. However, against an ever-evolving digital backdrop, it's imperative for private equity firms to prioritize cybersecurity throughout the entire investment lifecycle. David A. Dunn, Head of EMEA Cybersecurity, shares best practices: https://lnkd.in/es8t4Vww #Cybersecurity #PrivateEquity

Pricing in an industry like pharma is nuanced, but truely understanding net realized prices is critical in strategic decision making for pharma. This is a great and thoughtful piece from my life sciences colleagues in L.E.K. Consulting‘s pricing team. #pricing

13

Discover how FTI Consulting helped a high-growth dental services organization address liquidity and debt issues by uncovering approximately $24 million in potential EBITDA improvements. Dive into the full case study here: https://lnkd.in/ecFz7K7e

7

Hot off the presses --- Global #Healthcare #PrivateEquity -- Bain's 2025 Global Healthcare Private Equity Report is here! Our experts dive into key industry trends driving deal activity, including sellers' increased focus on showcasing equity value-creation potential, buyers leveraging carve-outs to sustain deal volume, growing interest among dealmakers in Asia-Pacific opportunities, and the evolving investment strategies mid-market firms need to maintain strong performance. https://bit.ly/4j7dDu2

2

Learn how my FTI Consulting colleagues helped a PE-backed urology medical service organization by assuming their integration activities and completing 8 integrations of acquisitions within four months of their purchase date: https://lnkd.in/eGfwTebc

2